Compass Pathways
CMPS
130 hedge funds and large institutions have $206M invested in Compass Pathways in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 15 closing their positions.
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
20% more capital invested
Capital invested by funds: $172M → $206M (+$34.1M)
7% more funds holding
Funds holding: 122 → 130 (+8)
6.21% more ownership
Funds ownership: 41.72% → 47.92% (+6.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 29
46% less call options, than puts
Call options by funds: $4.21M | Put options by funds: $7.82M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$12.3M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$10.9M |
| 3 |
Morgan Stanley
New York
|
+$6.48M |
| 4 |
SCM
Sio Capital Management
New York
|
+$4.38M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
-$8.3M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.5M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$2.59M |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$1.41M |
| 5 |
Renaissance Technologies
New York
|
-$1.29M |
CMPS Hedge Fund Activity: Q3 2024 in Review
130 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Compass Pathways (CMPS) for Q3 2024, worth a combined $206M — up 20% from $172M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new CMPS positions and 15 closed out — a net gain of 8 holders — while 27 added to existing stakes and 29 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $12.3M. The largest seller was Paradigm Biocapital Advisors, cutting an estimated $8.3M.
- 130 institutional investors held Compass Pathways (CMPS) as of Q3 2024, up from 122 in Q2 2024.
- Funds reported $206M of Compass Pathways stock for Q3 2024, up 20% quarter-over-quarter.
- 23 funds opened new Compass Pathways positions in Q3 2024 and 15 closed out, a net change of +8 holders.
- The largest Compass Pathways buyer in Q3 2024 was Citadel Advisors, an estimated $12.3M added.
- The largest Compass Pathways seller in Q3 2024 was Paradigm Biocapital Advisors, an estimated $8.3M sold.
Based on aggregated 13F filings for Q3 2024.